No association is found between the candidate genes of t-PA/plasminogen system and Japanese methamphetamine-related disorder - A collaborative study by the Japanese genetics initiative for drug abuse

被引:12
作者
Iwata, N [1 ]
Inada, T
Harano, M
Komiyama, T
Yamada, M
Sekine, Y
Iyo, M
Sora, I
Ujike, H
Ozaki, N
机构
[1] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Psychiat & Psychobiol, Nagoya, Aichi, Japan
[3] Kurume Univ, Sch Med, Dept Neuropsychiat, Kurume, Fukuoka 830, Japan
[4] Natl Ctr Hosp Mental Nervous & Muscular Disorders, Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan
[5] Showa Univ, Sch Med, Karasuyama Hosp, Tokyo 142, Japan
[6] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 43131, Japan
[7] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan
[8] Tohoku Univ, Grad Sch Med, Dept Neurosci, Div Psychobiol, Sendai, Miyagi 980, Japan
[9] Okayama Univ, Grad Sch Med & Dent, Dept Neuropsychiat, Okayama, Japan
来源
CURRENT STATUS OF DRUG DEPENDENCE / ABUSE STUDIES: CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY | 2004年 / 1025卷
关键词
tissue-plasminogen activator; plasminogen activator inhibitor; plasminogen; methamphetamine; drug dependence; polymorphisms; association study;
D O I
10.1196/annals.1316.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the central nervous system, tissue-plasminogen activator (t-PA)/plasmin system is involved in long-term synaptic plasticity and remodeling, and participates in rewarding effects of methamphetamine (MAP), by acutely regulating MAP-induced dopamine release in the nucleus accumbens. The aim of this study was to examine the relationships between the patients with MAP abusers/psychosis and the t-PA/plasminogen system genes. Subjects comprised 185 MAP abusers and 288 healthy controls. Four polymorphisms in the t-PA, plasminogen activator inhibitor, and plasminogen genes were examined in the present study. No significant differences were observed in each polymorphism between healthy controls and MAP abusers/psychosis. This study suggests that t-PA/plasminogen system is unlikely to he a major contributor to the substance abuse liability and/or the development of MAP psychosis.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 11 条
[1]   Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data [J].
Fallin, D ;
Schork, NJ .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) :947-959
[2]   Genetic analysis of case/control data using estimated haplotype frequencies: Application to APOE locus variation and Alzheimer's disease [J].
Fallin, D ;
Cohen, A ;
Essioux, L ;
Chumakov, I ;
Blumenfeld, M ;
Cohen, D ;
Schork, NJ .
GENOME RESEARCH, 2001, 11 (01) :143-151
[3]   Psychotomimetic-induction of tissue plasminogen activator mRNA in corticostriatal neurons in rat brain [J].
Hashimoto, T ;
Kajii, Y ;
Nishikawa, T .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (11) :3387-3399
[4]   Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins [J].
Kendler, KS ;
Karkowski, LM ;
Neale, MC ;
Prescott, CA .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (03) :261-269
[5]   The new genomics: Global views of biology [J].
Lander, ES .
SCIENCE, 1996, 274 (5287) :536-539
[6]   Familial transmission of substance use disorders [J].
Merikangas, KR ;
Stolar, M ;
Stevens, DE ;
Goulet, J ;
Preisig, MA ;
Fenton, B ;
Zhang, HP ;
O'Malley, SS ;
Rounsaville, BJ .
ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (11) :973-979
[7]   Linkage disequilibrium in the human genome [J].
Reich, DE ;
Cargill, M ;
Bolk, S ;
Ireland, J ;
Sabeti, PC ;
Richter, DJ ;
Lavery, T ;
Kouyoumjian, R ;
Farhadian, SF ;
Ward, R ;
Lander, ES .
NATURE, 2001, 411 (6834) :199-204
[8]   The 4G/4G genotype of the 4G/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene is a determinant of penetrating behaviour in patients with Crohn's disease [J].
Sans, M ;
Tàssies, D ;
Pellisé, M ;
Espinosa, G ;
Quintó, L ;
Piqué, JM ;
Reverter, JC ;
Panés, J .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) :1039-1047
[9]  
SATO M, 1983, BIOL PSYCHIAT, V18, P429
[10]  
Tishkoff SA, 1996, HUM GENET, V97, P759